NCT06533969 Assessment of Neural Signals for the Control of Assistive Devices
| NCT ID | NCT06533969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Spinal Cord Injury (SCI), Initial Encounter |
| Study Type | INTERVENTIONAL |
| Enrollment | 3 participants |
| Start Date | 2024-09-06 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3 participants in total. It began in 2024-09-06 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will investigate the use of motor intention-based cortical signals to trigger epidural spinal cord stimulation (ESCS) with individuals with SCI. Motor intention of UL tasks will be decoded using brain-computer interface (BCI) system based on cortical signals recorded using an Electroencephalographic (EEG) system or using their intracranially implanted devices Electrocorticographic (ECoG).
Eligibility Criteria
Inclusion Criteria: * Patients age 18 and older * Able to sign informed consent * Not participating in other studies that limit participation * Chronic (\>6 month) traumatic Spinal Cord Injury (SCI) (C4-T1 neurological injury with American Spinal Injury Association Impairment Scale (AIS A-D) with some residual function. Exclusion Criteria: * Patients that are pregnant * Patients under the age of 18 * Patients unable to provide informed consent
Contact & Investigator
Jonathan R Jagid, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06533969 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injury (SCI), Initial Encounter. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06533969 currently recruiting?
Yes, NCT06533969 is actively recruiting participants. Contact the research team at lfisher@miami.edu for enrollment information.
Where is the NCT06533969 trial being conducted?
This trial is being conducted at Miami, United States, Miami, United States.
Who is sponsoring the NCT06533969 clinical trial?
NCT06533969 is sponsored by University of Miami. The principal investigator is Jonathan R Jagid, MD at University of Miami. The trial plans to enroll 3 participants.